Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies

EINSTEIN-Jr Phase 2 Investigators, Paul Monagle, Anthonie W.A. Lensing, Kirstin Thelen, Ida Martinelli, Christoph Male, Amparo Santamaría, Elena Samochatova, Riten Kumar, Susanne Holzhauer, Paola Saracco, Paolo Simioni, Jeremy Robertson, Gernot Grangl, Jacqueline Halton, Phillip Connor, Guy Young, Angelo C. Molinari, Ulrike Nowak-Göttl, Gili KenetStefanie Kapsa, Stefan Willmann, Akos F. Pap, Michael Becka, Teresa Twomey, Jan Beyer-Westendorf, Martin H. Prins, Dagmar Kubitza

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies'. Together they form a unique fingerprint.

Medicine & Life Sciences